EMA Authorised: Veltassa (patiromer sorbitex calcium) — Vifor Fresenius Medical Care Renal Pharma France

View source ↗

Summary

The European Medicines Agency authorised Veltassa (patiromer sorbitex calcium) for the treatment of hyperkalemia; the marketing authorization holder in France i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Veltassa (patiromer)

Snippet

Status: Authorised. Therapeutic area: Hyperkalemia. MAH: Vifor Fresenius Medical Care Renal Pharma France. Decision date: 06/06/2024